Biotech · Private company · Sa, CA, US
Loki Therapeutics, Inc.
Track this companyFree. Adds Loki Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- Lm-LLO-TTPhase 1 · Pancreas Cancer, Duct Cell AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Lm-LLO-TT and Gemcitabine in Unresectable Pancreatic Ductal AdenocarcinomaPHASE1 · RECRUITING · started Oct 15, 2026ClinicalTrials.gov NCT07828236 · fetched Nov 12, 2026
NIH awards2
- Clinical testing of Listeria-TT and Gemcitabine in a Phase I clinical trial with PDAC patientsFiscal year 2026 · $726.6KNIH RePORTER 4R42CA287679-02 · fetched Nov 12, 2026
- Clinical testing of Listeria-TT and Gemcitabine in a Phase I clinical trial with PDAC patientsFiscal year 2024 · $295KNIH RePORTER 1R42CA287679-01 · fetched Nov 12, 2026